$538.20M
Revenue
$-2.80M
Net Income
75.21%
Gross Margin
4.89%
Op. Margin
$-21.30M
Free Cash Flow
| Breakdown | Q4 2025 (Feb 28, 2025) |
Q3 2025 (Nov 30, 2025) |
Q2 2025 (Aug 31, 2025) |
Q1 2025 (May 31, 2025) |
|---|---|---|---|---|
| Total Revenue | $143.90M | $143.00M | $145.00M | $121.70M |
| Revenue Growth % (YoY) | nan% | nan% | nan% | nan% |
| Cost of Revenue | $38.00M | $31.00M | $51.00M | $31.40M |
| Gross Profit | $105.90M | $112.00M | $94.00M | $90.30M |
| Gross Margin % | 73.6% | 78.3% | 64.8% | 74.2% |
| Operating Expenses | $112.10M | $93.00M | $115.00M | $88.30M |
| Research & Development | $23.80M | $27.00M | $37.00M | $25.00M |
| Operating Income | $-6.20M | $19.00M | $-21.00M | $2.00M |
| Operating Margin % | -4.3% | 13.3% | -14.5% | 1.6% |
| Income Before Tax | $-6.50M | $19.00M | $-18.00M | $4.90M |
| Income Tax Expense | $1.00M | $7.00M | $1.00M | $3.00M |
| Net Income | $-7.00M | $-11.00M | $-19.00M | $1.90M |
| Net Margin % | -4.9% | -7.7% | -13.1% | 1.6% |
| Basic EPS | -0.01 | -0.02 | -0.03 | 0.00 |
| Diluted EPS | -0.01 | -0.02 | -0.03 | 0.00 |
| Breakdown | Q4 2025 (Feb 28, 2025) |
Q3 2025 (Nov 30, 2025) |
Q2 2025 (Aug 31, 2025) |
Q1 2025 (May 31, 2025) |
|---|---|---|---|---|
| Cash & Cash Equivalents | $266.70M | $189.00M | $171.00M | $276.00M |
| Short-term Investments | $71.10M | $31.00M | $40.00M | $30.60M |
| Accounts Receivable | $173.70M | $161.00M | $150.00M | $129.90M |
| Other Current Assets | $30.00M | $39.00M | $52.00M | $43.30M |
| Total Current Assets | $591.50M | $455.00M | $438.00M | $533.20M |
| Property Plant & Equipment | $13.40M | $14.00M | $17.00M | $12.70M |
| Goodwill | $472.40M | $473.00M | $563.00M | $476.90M |
| Intangible Assets | $47.30M | $51.00M | $136.00M | $44.20M |
| Long-term Investments | $58.90M | $35.00M | $37.00M | $58.80M |
| Other Non-current Assets | $76.50M | $73.00M | $59.00M | $48.00M |
| Total Assets | $1.30B | $1.31B | $1.30B | $1.21B |
| Accounts Payable | $31.10M | $9.00M | $7.00M | $5.20M |
| Accrued Liabilities | $126.20M | $97.00M | $109.00M | $83.30M |
| Deferred Revenue | $161.50M | $133.00M | $161.00M | $136.30M |
| Total Current Liabilities | $344.30M | $332.00M | $305.00M | $253.40M |
| Long-term Debt | $195.30M | $196.20M | $195.90M | $195.60M |
| Other Non-current Liabilities | $1.80M | $1.00M | $1.00M | $1.20M |
| Total Liabilities | $575.70M | $584.00M | $567.00M | $485.30M |
| Common Stock | $2.98B | $2.97B | $2.96B | $2.97B |
| Retained Earnings | $-2.24B | $-2.23B | $-2.22B | $-2.23B |
| Total Stockholders Equity | $719.90M | $725.00M | $732.00M | $725.10M |
| Total Liabilities & Equity | $1.30B | $1.31B | $1.30B | $1.21B |
| Breakdown | Q4 2025 (Feb 28, 2025) |
Q3 2025 (Nov 30, 2025) |
Q2 2025 (Aug 31, 2025) |
Q1 2025 (May 31, 2025) |
|---|---|---|---|---|
| Net Income | $-7.00M | $-72.00M | $-19.00M | $1.90M |
| Depreciation & Amortization | $5.70M | $39.00M | $26.00M | $5.70M |
| Stock-based Compensation | $4.60M | $21.00M | $15.00M | $5.70M |
| Change in Receivables | $2.00M | $-27.00M | $-49.00M | $-43.80M |
| Change in Payables | $21.20M | $-7.00M | $-10.00M | $-25.90M |
| Operating Cash Flow | $41.50M | $-25.00M | $-28.00M | $-18.00M |
| Capital Expenditure | $100.00K | $3.00M | $3.00M | $900.00K |
| Investing Cash Flow | $38.70M | $22.00M | $15.00M | $38.50M |
| Debt Repayment | - | - | - | - |
| Stock Issued | $100.00K | $3.00M | $1.00M | $1.20M |
| Stock Repurchased | - | $4.00M | $30.00M | $10.00M |
| Financing Cash Flow | $100.00K | $3.00M | $1.00M | $-8.80M |
| Net Change in Cash | $79.80M | - | $-12.00M | $12.20M |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Nov 30, 2025
Condensed Consolidated Statements of Operations
| Description | Nov 30, 2025 | Nov 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $141.80M | $143.60M | $393.10M | $393.20M |
| Cost of Revenue | $31.90M | $31.40M | $96.30M | $102.40M |
| Gross Profit | $109.90M | $112.20M | $296.80M | $290.80M |
| Operating Expenses | $98.00M | $92.70M | $271.40M | $282.00M |
| Research & Development | $29.60M | $27.90M | $80.20M | $85.60M |
| Operating Income | $11.90M | $19.50M | $25.40M | $8.80M |
| Income Before Tax | $14.80M | $18.90M | $33.10M | $14.90M |
| Income Tax Expense | $1.10M | $6.60M | $4.20M | $15.60M |
| Net Income | $13.70M | $-10.50M | $28.90M | $-71.60M |
| Basic EPS | 0.02 | -0.02 | 0.05 | -0.12 |
| Diluted EPS | 0.02 | -0.02 | 0.05 | -0.12 |
Condensed Consolidated Balance Sheets
| Description | Nov 30, 2025 | Feb 28, 2025 |
|---|---|---|
| Cash & Cash Equivalents | $270.30M | $266.70M |
| Short-term Investments | $33.90M | $71.10M |
| Accounts Receivable | $149.50M | $173.70M |
| Other Current Assets | $38.40M | $30.00M |
| Total Current Assets | $543.20M | $591.50M |
| Property Plant & Equipment | $11.70M | $13.40M |
| Goodwill | $478.10M | $472.40M |
| Intangible Assets | $40.70M | $47.30M |
| Long-term Investments | $59.30M | $58.90M |
| Other Non-current Assets | $53.70M | $76.50M |
| Total Assets | $1.22B | $1.30B |
| Accounts Payable | $13.40M | $31.10M |
| Accrued Liabilities | $106.10M | $126.20M |
| Deferred Revenue | $121.30M | $161.50M |
| Total Current Liabilities | $253.30M | $344.30M |
| Long-term Debt | $196.20M | $195.30M |
| Other Non-current Liabilities | $1.80M | $1.80M |
| Total Liabilities | $477.30M | $575.70M |
| Common Stock | $2.95B | $2.98B |
| Retained Earnings | $-2.20B | $-2.24B |
| Total Stockholders Equity | $741.10M | $719.90M |
| Total Liabilities & Equity | $1.22B | $1.30B |
Condensed Consolidated Statements of Cash Flows
| Description | Nov 30, 2025 | Nov 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $13.70M | $-10.50M | $28.90M | $-71.60M |
| Depreciation & Amortization | $2.40M | $4.40M | $14.30M | $39.00M |
| Stock-based Compensation | - | - | $17.70M | $21.30M |
| Change in Receivables | - | - | $-24.20M | $-26.40M |
| Change in Payables | - | - | $-17.70M | $-7.20M |
| Operating Cash Flow | - | - | $4.20M | $-25.10M |
| Capital Expenditure | - | - | $2.60M | $2.70M |
| Investing Cash Flow | - | - | $30.80M | $22.10M |
| Stock Issued | - | - | $2.50M | $3.10M |
| Stock Repurchased | $4.00M | - | $34.00M | - |
| Financing Cash Flow | - | - | $-31.50M | $3.10M |
| Net Change in Cash | - | - | $4.00M | $-300.00K |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.